Immuron (NASDAQ: IMRN), plans IND submission for CDI treatment in 2025 Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company, has announced plans to submit an investigational new drug (IND) application for IMM-529, aimed at preventing or...
Bruker NASDAQ: BRKR) Acquires Dynamic Biosensors Bruker (NASDAQ: BRKR) Corporation (Nasdaq: BRKR) today announced the acquisition of Dynamic Biosensors GmbH, a pioneering company known for its breakthroughs in biosensor development, which is based in Munich, Germany....
Ollie's Bargain Outlet (NASDAQ: OLLI) Acquires Former Big Lots Stores Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today announced that it was the winning bidder in a bankruptcy sale process to acquire seven former Big Lots, Inc. (“Big Lots”)...
